Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-03

Clinical Trial Update: Adversity and Its Association With the Development and Expression of Rheumatic Diseases

View source ↗

Summary

Ongoing clinical trial exploring how adversity influences the development and expression of rheumatic diseases, including rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Medical Sciences and Nutrition, Salvador Zubiran | Conditions: RhA - Rheumatoid Arthritis | Status: NOT_YET_RECRUITING